Prenetics Global Limited
PRE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.01 | -0.01 | -0.00 |
| FCF Yield | -40.63% | -22.08% | 5.37% | 0.15% |
| EV / EBITDA | -0.53 | -0.48 | -0.06 | -8.42 |
| Quality | ||||
| ROIC | -22.78% | -23.73% | -25.76% | -61.58% |
| Gross Margin | 50.29% | 40.61% | 27.48% | 38.47% |
| Cash Conversion Ratio | 0.58 | 0.21 | -0.08 | -0.08 |
| Growth | ||||
| Revenue 3-Year CAGR | 32.50% | 20.16% | -41.33% | 10.72% |
| Free Cash Flow Growth | -103.99% | -279.60% | 307.73% | 133.74% |
| Safety | ||||
| Net Debt / EBITDA | 0.90 | 0.90 | 0.65 | 0.19 |
| Interest Coverage | -237.16 | -433.78 | -16.53 | -10.82 |
| Efficiency | ||||
| Inventory Turnover | 2.32 | 4.13 | 29.66 | 24.85 |
| Cash Conversion Cycle | 136.31 | 127.72 | 1,172.14 | 56.03 |